Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Harmony Wellness Clinic vs Human+

Harmony Wellness Clinic
Graded #308

Higher grade

vs+1.1000000000000014
Human+
Graded #333

Lower grade

The verdict

Harmony Wellness Clinic takes it — 60.9/100 to 59.8/100, but only just.

Harmony Wellness Clinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harmony Wellness Clinic is a LegitScript-certified telehealth platform offering compounded semaglutide (GLP-1 + B12) and compounded tirzepatide (GLP-1/GIP + B12) for medically supervised weight loss. Human+ is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationHarmony Wellness Clinic +24
64
40
Clinical oversightHuman+ +5
78
83
Labs & monitoringHuman+ +14
52
66
FulfillmentHuman+ +15
75
90
Contract termsHarmony Wellness Clinic +14
55
41
Harmony Wellness Clinic · left barHuman+ · right bar

The numbers

MetricHarmony Wellness ClinicHuman+
WeighScore60.9/10059.8/100
GradeCC
Scorecard rank#308#333
Semaglutide$200/mo (starting dose, compounded)Not disclosed
Tirzepatide$250/mo (starting dose, compounded)Not disclosed
Coverage36 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Harmony Wellness Clinic

Graded #308 · C

Strengths

  • LegitScript certified with licensed APRN-CNP clinical oversight by Kristina Stout
  • Two compounded GLP-1 options: semaglutide+B12 (5 dose levels) and tirzepatide+B12 (6 dose levels)
  • Partners with four named 503A compounding pharmacies for a transparent supply chain
  • Competitive starting prices: $200/month for semaglutide and $250/month for tirzepatide
  • Telehealth services available in 36 states via the Optimantra online patient portal

Where it loses points

  • 36-state coverage — many states including some large markets not served
  • Care led by APRN-CNP, not an MD or DO; no physician name disclosed
  • Pricing scales with dose level up to $300/month (sema) and $450/month (tirz)
  • Labs not mentioned or included on any public page — baseline bloodwork protocol unknown
  • No coaching or lifestyle program disclosed beyond clinical dose management
Human+

Graded #333 · C

Strengths

  • Cost-transparent model: a flat monthly membership with prescriptions billed at pharmacy-wholesale cost instead of marked up
  • Available via telehealth in all 50 states
  • Filled by US 503A compounding pharmacies and reviewed by board-certified US-licensed clinicians
  • Fast, fully online 5-minute intake with provider review often within hours; discreet plain packaging
  • Covers weight loss plus hair, sexual wellness, mental health, and labs under one membership

Where it loses points

  • Specific GLP-1 medications and pricing are not published — you only see them after starting the intake
  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • LegitScript certification is shown only as a self-hosted badge; no verifiable LegitScript seal was found
  • Minimal public-facing site and a flat membership fee on top of the medication cost

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard